Posts Tagged ‘prescription-based’
Click Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia
Boehringer Ingelheim, Click Therapeutics ink $500M+ digital therapeutics development, commercialization deal (MobiHealthNews): International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia.
Read More